UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:RAD51D-MAP2K4 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: RAD51D-MAP2K4 | FusionPDB ID: 71769 | FusionGDB2.0 ID: 71773 | Hgene | Tgene | Gene symbol | RAD51D | MAP2K4 | Gene ID | 5892 | 6416 |
Gene name | RAD51 paralog D | mitogen-activated protein kinase kinase 4 | |
Synonyms | BROVCA4|R51H3|RAD51L3|TRAD | JNKK|JNKK1|MAPKK4|MEK4|MKK4|PRKMK4|SAPKK-1|SAPKK1|SEK1|SERK1|SKK1 | |
Cytomap | 17q12 | 17p12 | |
Type of gene | protein-coding | protein-coding | |
Description | DNA repair protein RAD51 homolog 4RAD51 homolog DRAD51-like protein 3recombination repair protein | dual specificity mitogen-activated protein kinase kinase 4JNK-activated kinase 1JNK-activating kinase 1MAP kinase kinase 4MAPK/ERK kinase 4MAPKK 4MEK 4SAPK/ERK kinase 1c-Jun N-terminal kinase kinase 1stress-activated protein kinase kinase 1 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | P45985 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000335858, ENST00000345365, ENST00000360276, ENST00000394589, ENST00000460118, ENST00000590016, ENST00000590380, ENST00000357906, | ENST00000581941, ENST00000353533, ENST00000415385, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 3 X 4=48 | 8 X 10 X 6=480 |
# samples | 4 | 10 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/480*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: RAD51D [Title/Abstract] AND MAP2K4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RAD51D(33428220)-MAP2K4(11984673), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | RAD51D-MAP2K4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. RAD51D-MAP2K4 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RAD51D | GO:0042148 | strand invasion | 11834724 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | MESO | TCGA-3U-A98I-01A | RAD51D | chr17 | 33428220 | - | MAP2K4 | chr17 | 11984673 | + |
ChimerDB4 | MESO | TCGA-3U-A98I | RAD51D | chr17 | 33428220 | - | MAP2K4 | chr17 | 11984673 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000394589 | RAD51D | chr17 | 33428220 | - | ENST00000353533 | MAP2K4 | chr17 | 11984673 | + | 4587 | 1042 | 923 | 2023 | 366 |
ENST00000394589 | RAD51D | chr17 | 33428220 | - | ENST00000415385 | MAP2K4 | chr17 | 11984673 | + | 4594 | 1042 | 923 | 2023 | 366 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000394589 | ENST00000353533 | RAD51D | chr17 | 33428220 | - | MAP2K4 | chr17 | 11984673 | + | 0.001369176 | 0.9986308 |
ENST00000394589 | ENST00000415385 | RAD51D | chr17 | 33428220 | - | MAP2K4 | chr17 | 11984673 | + | 0.001360903 | 0.99863905 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >71769_71769_1_RAD51D-MAP2K4_RAD51D_chr17_33428220_ENST00000394589_MAP2K4_chr17_11984673_ENST00000353533_length(amino acids)=366AA_BP=39 MPSDAPGALCPALGFSWTPSREQEHQAAGAWRVWPNLPDRERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPS -------------------------------------------------------------- >71769_71769_2_RAD51D-MAP2K4_RAD51D_chr17_33428220_ENST00000394589_MAP2K4_chr17_11984673_ENST00000415385_length(amino acids)=366AA_BP=39 MPSDAPGALCPALGFSWTPSREQEHQAAGAWRVWPNLPDRERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:33428220/chr17:11984673) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | MAP2K4 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000345365 | - | 9 | 10 | 200_205 | 301.0 | 329.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000360276 | - | 8 | 9 | 200_205 | 256.0 | 284.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000394589 | - | 10 | 11 | 200_205 | 301.0 | 329.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000590016 | - | 9 | 10 | 200_205 | 321.0 | 349.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000335858 | - | 6 | 7 | 107_114 | 189.0 | 217.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000345365 | - | 9 | 10 | 107_114 | 301.0 | 329.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000360276 | - | 8 | 9 | 107_114 | 256.0 | 284.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000394589 | - | 10 | 11 | 107_114 | 301.0 | 329.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000590016 | - | 9 | 10 | 107_114 | 321.0 | 349.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000335858 | - | 6 | 7 | 1_83 | 189.0 | 217.0 | Region | Note=preferentially binds ssDNA |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000345365 | - | 9 | 10 | 1_83 | 301.0 | 329.0 | Region | Note=preferentially binds ssDNA |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000360276 | - | 8 | 9 | 1_83 | 256.0 | 284.0 | Region | Note=preferentially binds ssDNA |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000394589 | - | 10 | 11 | 1_83 | 301.0 | 329.0 | Region | Note=preferentially binds ssDNA |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000590016 | - | 9 | 10 | 1_83 | 321.0 | 349.0 | Region | Note=preferentially binds ssDNA |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000353533 | 1 | 11 | 102_367 | 72.66666666666667 | 400.0 | Domain | Protein kinase | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000415385 | 2 | 12 | 102_367 | 83.66666666666667 | 411.0 | Domain | Protein kinase | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000353533 | 1 | 11 | 108_116 | 72.66666666666667 | 400.0 | Nucleotide binding | ATP | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000415385 | 2 | 12 | 108_116 | 83.66666666666667 | 411.0 | Nucleotide binding | ATP | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000353533 | 1 | 11 | 364_387 | 72.66666666666667 | 400.0 | Region | Note=DVD domain | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000415385 | 2 | 12 | 364_387 | 83.66666666666667 | 411.0 | Region | Note=DVD domain |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000335858 | - | 6 | 7 | 200_205 | 189.0 | 217.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000357906 | - | 1 | 4 | 200_205 | 0 | 119.0 | Compositional bias | Note=Poly-Val |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000357906 | - | 1 | 4 | 107_114 | 0 | 119.0 | Nucleotide binding | ATP |
Hgene | RAD51D | chr17:33428220 | chr17:11984673 | ENST00000357906 | - | 1 | 4 | 1_83 | 0 | 119.0 | Region | Note=preferentially binds ssDNA |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000353533 | 1 | 11 | 5_19 | 72.66666666666667 | 400.0 | Compositional bias | Note=Gly/Ser-rich | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000415385 | 2 | 12 | 5_19 | 83.66666666666667 | 411.0 | Compositional bias | Note=Gly/Ser-rich | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000353533 | 1 | 11 | 37_52 | 72.66666666666667 | 400.0 | Region | Note=D domain | |
Tgene | MAP2K4 | chr17:33428220 | chr17:11984673 | ENST00000415385 | 2 | 12 | 37_52 | 83.66666666666667 | 411.0 | Region | Note=D domain |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>724_RAD51D_33428220_MAP2K4_11984673_ranked_0.pdb | RAD51D | 33428220 | 33428220 | ENST00000415385 | MAP2K4 | chr17 | 11984673 | + | MPSDAPGALCPALGFSWTPSREQEHQAAGAWRVWPNLPDRERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPS | 366 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
RAD51D_pLDDT.png![]() |
MAP2K4_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
RAD51D | |
MAP2K4 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to RAD51D-MAP2K4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RAD51D-MAP2K4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |